Welty Thomas K, Bulterys Marc, Welty Edith R, Tih Pius M, Ndikintum George, Nkuoh Godlove, Nkfusai Joseph, Kayita Janet, Nkengasong John N, Wilfert Catherine M
Cameroon Baptist Convention Health Board, Nso, Northwest Province, Cameroon.
J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):486-93. doi: 10.1097/01.qai.0000163196.36199.89.
With funds from Elizabeth Glaser Pediatric AIDS Foundation, the Cameroon Baptist Convention Health Board implemented a program to prevent mother-to-child transmission of HIV-1 (PMTCT) as part of its routine antenatal care, with single-dose maternal and infant peripartum nevirapine (NVP) prophylaxis of HIV-positive mothers and their babies. Nurses, midwives, nurse aides, and trained birth attendants counseled pregnant women, obtained risk factor data, and offered free HIV testing with same-day results. From February 2000 through December 2004, this program rapidly expanded to 115 facilities in 6 of Cameroon's 10 provinces, not only to large hospitals but to remote health centers staffed by trained birth attendants. We trained 690 health workers in PMTCT and counseled 68,635 women, 91.9% of whom accepted HIV testing. Of 63,094 women tested, 8.7% were HIV-1-positive. Independent risk factors for HIV-1 infection included young age at first sexual intercourse, multiple sex partners, and positive syphilis serology (P < 0.001 for each). We counseled 98.7% of positive and negative mothers on a posttest basis. Of 5550 HIV-positive mothers, we counseled 5433 (97.9%) on single-dose NVP prophylaxis. Consistent training and programmatic support contributed to rapid upscaling and high uptake and counseling rates.
在伊丽莎白·格拉泽儿童艾滋病基金会的资助下,喀麦隆浸信会健康委员会实施了一项预防HIV-1母婴传播(PMTCT)的项目,作为其常规产前护理的一部分,为HIV阳性母亲及其婴儿提供单剂量的母婴围产期奈韦拉平(NVP)预防治疗。护士、助产士、护士助理和经过培训的接生员为孕妇提供咨询,获取风险因素数据,并提供当日出结果的免费HIV检测。从2000年2月到2004年12月,该项目迅速扩展到喀麦隆10个省中的6个省的115个机构,不仅包括大型医院,还包括由经过培训的接生员配备人员的偏远健康中心。我们对690名卫生工作者进行了PMTCT培训,并为68635名妇女提供了咨询,其中91.9%的妇女接受了HIV检测。在63094名接受检测的妇女中,8.7%为HIV-1阳性。HIV-1感染的独立风险因素包括初次性交年龄小、多个性伴侣和梅毒血清学阳性(每项P<0.001)。我们在检测后为98.7%的阳性和阴性母亲提供了咨询。在5550名HIV阳性母亲中,我们为5433名(97.9%)提供了单剂量NVP预防治疗的咨询。持续的培训和项目支持有助于快速扩大规模以及提高接受率和咨询率。